Breathe Well Live Well
|
BRIEF-GSK submits application for Japanese approval of asthma drug
Reuters May 22 GlaxoSmithKline Plc : * Submits Japan regulatory application for mepolizumab in severe eosinophilic asthma. * Mepolizumab is an anti il-5 monoclonal antibody delivered in a 100mg fixed dose via a subcutaneous injection every four weeks. |
View full post on asthma – Google News
|
Glaxo submits new asthma drug application in Japan
MarketWatch LONDON–Pharmaceutical company GlaxoSmithKline PLC (GSK.LN) said Friday it has submitted a new drug application to the Japanese health ministry for mepolizumab, a drug used for treating a type of severe asthma. The application for mepolizumab has … Glaxo Submits Japan Application For Mepolizumab In Eosinophilic Asthma |
View full post on asthma – Google News
|
Application process underway for Hasbro's Asthma Camp
Turn to 10 This is the only overnight camp in the state for children nine-13 who suffer from asthma. Asthma Camp gives children the opportunity to learn to actively manage their asthma in a positive, healthy, safe and challenging atmosphere. On-site, 24-hour … |
View full post on asthma – Google News
|
FDA to review new drug application for Spiriva Respimat for asthma
Healio Boehringer Ingelheim Pharmaceuticals announced that the FDA has agreed to review its new drug application for tiotropium bromide inhalation spray for long-term maintenance of patients aged 12 years and older with asthma, according to a press release. Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug … |
View full post on asthma – Google News
|
Glaxo, Theravance File Asthma Drug Application with FDA
NASDAQ LONDON–GlaxoSmithKline PLC (GSK.LN) and Theravance Inc. ( THRX ) have submitted a supplemental new drug application to the U.S. Food and Drug Administration for a drug used for treatment of asthma in patients aged 12 years and older. The British … GSK and Theravance Announce Submission to US Regulatory Authorities for … Glaxo And Theravance Submits Supplemental NDA For Breo Ellipta |
View full post on asthma – Google News
Condition: BRONCHIAL ASTHMA
Intervention: Device: SMART ARM
Sponsors: Inje University; Inje University
Recruiting – verified August 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Researchers use mobile application to improve asthma outcomes among …
News-Medical.net Researchers at Rush University Medical Center in Chicago, IL and The University of Illinois at Chicago are using the Internet and motivational multimedia coupled with positive reinforcement via a smartphone application to try to improve asthma outcomes … |
View full post on asthma – Google News
|
Mylan faces lawsuit over asthma drug application
Bloomberg … filed with the Food and Drug Administration to make a generic version of Orapred, a steroid used to reduce inflammation in asthma and other conditions. … |
View full post on asthma – Google News